Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.739644
Title: Diagnosing cancer one cell at a time with single molecule spectroscopy
Author: Magness, Alastair
ISNI:       0000 0004 7229 0465
Awarding Body: Imperial College London
Current Institution: Imperial College London
Date of Award: 2018
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Mapping protein expression heterogeneity in cancer at single cell resolution is essential for the understanding of disease progression, emergent drug resistance, and metastasis, but is a great technical challenge. Longitudinal monitoring of heterogeneity pertaining to biomarker expression may provide the necessary medical cues for the administering of personalised therapeutics. Studying molecular heterogeneity in the ultra-rare circulating tumour cells [CTCs] found in the blood of cancer patients is a greater challenge still, but success may yield deep insight into the nature of the metastatic cascade, and also provide the technologi-cal means of a non-invasive ‘liquid biopsy’. The MAC chip is a quantitative single molecule sensitive protein assay for the evalua-tion of protein copy number in single cells. In this thesis, we attempt the development of a new biomarker-targeting MAC chip assay for the breast cancer oncoprotein estrogen recep-tor alpha. We describe a series of improvements to the MAC chip assay architecture allow-ing multiplexed measurement of several proteins simultaneously, and improvements to analysis methods allowing for superior molecule counting. Building on the work of others in the field of circulating tumour cell isolation, we attempt the integration of the MAC chip analysis method into a multiple-stage device for the isolation and proteomic analysis of cir-culating tumour cells. Finally, using a multiplexed MAC chip device for the tumour sup-pressor protein p53 and its activated form phosphorylated at serine-15, we demonstrate for the first time that the MAC chip can be used to study protein expression heterogeneity in quasi-clinical samples. The patient-derived xenografts we use to perform this work are a key resource of clinically-relevant tumour material, and a model system directly analogous to primary patient biopsies, thus demonstrating the feasibility of translational single cell pro-teomics with the MAC chip system.
Supervisor: Klug, David ; Willison, Keith ; Coombes, Charles ; Ali, Simak Sponsor: Engineering and Physical Sciences Research Council ; Cancer Research UK ; Institute of Chemical Biology
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.739644  DOI:
Share: